135
Participants
Start Date
December 4, 2020
Primary Completion Date
April 9, 2024
Study Completion Date
October 31, 2028
Inebilizumab
Inebilizumab is a monoclonal antibody that depletes B cells.
Placebo
Placebo
Viela Bio Investigative Site, Baltimore
Viela Bio Investigative Site, Atlanta
Viela Bio Investigative Site, Palo Alto
Viela Bio Investigative Site, Boston
Viela Bio Investigative Site, Buenos Aires
Viela Bio Investigative Site, Mendoza
Viela Bio Investigative Site, Auchenflower
Viela Bio Investigative Site, Adelaide
Viela Bio Investigative Site, Fitzroy
Viela Bio Investigative Site, Sherbrooke
Viela Bio Investigative Site 1, Toronto
Viela Bio Investigative Site 2, Toronto
Viela Bio Investigative Site, Hohhot
Viela Bio Investigative Site 1, Beijing
Viela Bio Investigative Site 2, Beijing
Viela Bio Investigative Site 3, Beijing
Viela Bio Investigative Site 4, Beijing
Viela Bio Investigative Site 5, Beijing
Viela Bio Investigative Site, Guandong
Viela Bio Investigative Site, Shang’ai
Viela Bio Investigative Site, Shenyang
Viela Bio Investigative Site, Wuhan
Viela Bio Investigative Site, Clichy
Viela Bio Investigative Site, Lille
Viela Bio Investigative Site, Marseille
Viela Bio Investigative Site, Nantes
Viela Bio Investigative Site, Pessac
Viela Bio Investigative Site, Berlin
Viela Bio Investigative Site, Lübeck
Viela Bio Investigative Site, München
Viela Bio Investigative Site, Hong Kong
Viela Bio Investigative Site, Debrecen
Viela Bio Investigative Site, Szeged
Viela Bio Investigative Site, Bangalore
Viela Bio Investigative Site, Cork
Viela Bio Investigative Site, Kfar Saba
Viela Bio Investigative Site, Petah Tikva
Viela Bio Investigative Site, Tel Aviv
Viela Bio Investigative Site, Tel Litwinsky
Viela Bio Investigative Site, Florence
Viela Bio Investigative Site, Milan
Viela Bio Investigative Site, Pisa
Viela Bio Investigative Site, Reggio Emilia
Viela Bio Investigative Site, Torino
Viela Bio Investigative Site, Verona
Viela Bio Investigative Site, Fukuoka
Viela Bio Investigative Site, Hokkaido
Viela Bio Investigative Site, Hyōgo
Viela Bio Investigative Site, Ishikawa
Viela Bio Investigative Site, Kyoto
Viela Bio Investigative Site, Niigata
Viela Bio Investigative Site 2, Osaka
Viela Bio Investigative Site, Osaka
Viela Bio Investigative Site, Tokyo
Viela Bio Investigative Site, Toyama
Viela Bio Investigative Siite, Tlalpan
Viela Bio Investigative Site, Amsterdam
Viela Bio Investigative Site, Rotterdam
Viela Bio Investigative Site, Warsaw
Viela Bio Investigative Site, Wroclaw
Viela Bio Investigative Site 2, Barcelona
Viela Bio Investigative Site, Barcelona
Viela Bio Investigative Site, Madrid
Viela Bio Investigative Site, Valencia
Viela Bio Investigative Site, Gothenburg
Viela Bio Investigative Site, Stockholm
Viela Bio Investigative Site, Ankara
Viela Bio Investigative Site, Istanbul
Viela Bio Investigative Site, Leeds
Viela Bio Investigative Site, London
Viela Bio Investigative Site, Newcastle
Viela Bio Investigative Site, Oxford
Lead Sponsor
Amgen
INDUSTRY